Mendoza
Mendoza v. Monsanto Company
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
IN RE: ROUNDUP PRODUCTS MDL No. 2741
LIABILITY LITIGATION
Case No. 16-md-02741-VC
This document relates to: SUGGESTION OF REMAND TO
TRANSFEROR COURT
Mendoza v. Monsanto, Case No. 16-cv- 06046
This suggestion of remand is for Plaintiff Yolanda Mendoza whose case was transferred to this MDL from the Eastern District of California. I. In March 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” The classification stemmed from scientific studies that found an association between glyphosate exposure and non-Hodgkin lymphoma (NHL). Glyphosate is the active ingredient in Monsanto’s widely used weedkiller Roundup, and the IARC classification prompted people with NHL to file lawsuits against Monsanto in federal and state courts across the country, primarily alleging that Monsanto failed to warn them about the cancer risks posed by Roundup. In October 2016, the Panel created this MDL for federal court cases in which plaintiffs allege that Roundup caused their NHL. In re Roundup Products Liability Litigation, 214 F. Supp. 3d 1346 (J.P.M.L.…